Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Detemir and Sitagliptin on Blood Glucose Control in Subjects With Type 2 Diabetes Mellitus

NCT00789191 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00789191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00789191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Detemir and Sitagliptin on Blood Glucose Control in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
August 31, 2009
Enrollment
222 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2